MedTrace Logo

PRESERVE-MITRAL Post-Market Registry

NCT03283722 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 200

Last updated 2025-02-11

Study results available
· View outcomes & findings →

Summary

The objective of this registry is to gather data on the clinical outcomes of Medtronic mitral repair products (Profile 3D™ and CG Future® annuloplasty systems) in the approved intended use up to 12 months from the day of procedure

Conditions

  • Mitral Valve Disease

Interventions

DEVICE

Profile 3D™ and CG Future® annuloplasty system

Patients suffering from mitral valve disease and indicated for a mitral valve repair procedure with Profile 3D™ and CG Future® annuloplasty system as part of standard of care, in accordance with the product label indications (instructions for use), contraindications, and warnings

Sponsors & Collaborators

  • Medtronic Cardiac Surgery

    lead INDUSTRY

Principal Investigators

  • Vinay Rajan, Ph.D · Medtronic

Eligibility

Min Age
18 Years
Max Age
99 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-04-10
Primary Completion
2021-02-10
Completion
2021-02-10

Countries

  • Bangladesh
  • India
  • Nepal

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03283722 on ClinicalTrials.gov